Navigation Links
Share Issue Gives Cellectricon SEK 89 Million to Continue its Rapid Market Expansion
Date:2/21/2008

GOTHENBURG, Sweden, February 21 /PRNewswire/ -- With two successful international product launches, Swedish biotech firm Cellectricon is entering a new expansion phase. The share issue will strengthen Cellectricon's financial capacity prior to a number of significant product launches in 2008-2009. These products have been developed in close collaboration with leading global pharmaceutical companies to meet the industry's increasing demand for fully automated, highly efficient systems for pre-clinical pharmaceutical development.

"Cellectricon is now entering a new expansion phase, in which the company will soon launch two large-scale systems that will revolutionize drug discovery. This capital will enable us to continue our rapid expansion in the United States, Europe, and Asia," said Dr. Mattias Karlsson, Cellectricon's CEO.

In 2008 Cellectricon will launch the first of their large-scale screening system, Cellaxess(R)HT, which has been developed in close cooperation with one of the world's largest pharmaceutical companies. Cellaxess(R)HT will be the only system on the market that enables large-scale supply of genetic material for cells and is tailor made for high throughput RNAi screening.

About Cellectricon

Cellectricon AB is a Swedish biotech company that is a successful provider of groundbreaking products to the pharmaceutical industry that increase efficiency in pre-clinical pharmaceutical development. Cellectricon has already successfully launched two products onto the market that have been sold to ten of the 12 largest pharmaceutical companies in the world. In 2007 the company increased its revenue by almost 50%. In 2008-2009 launch the high-performance systems Cellaxess(R)HT for RNAi screening and Dynaflow(R)HT for ion channel screening. Cellectricon's forthcoming products address a market that is estimated to be US $1.4 billion by 2010.


'/>"/>
SOURCE Cellectricon AB
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
3. CardioDynamics Provides 2007 Shareholder Meeting Update
4. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
5. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
6. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
7. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
8. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
9. Neuralstem Shares Accepted for Trading on Amex(R)
10. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
11. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 Today, at the American ... , James McGough , M.D., ... the Semel Institute for Neuroscience and Human Behavior and ... at the University of California Los Angeles (UCLA), and ... Adolescent Psychopharmacology and ADHD at UCLA, presented the results ...
(Date:5/20/2013)... , May 20, 2013   BioHealth ... focusing on commercializing market-relevant biohealth innovations and increasing ... Maryland , today announced its selection of ... (EIR) for BHI at the National Institutes of ... Institute (NHLBI). Dr. Aiyar will help advance ...
(Date:5/20/2013)... Researchers from the Southern University of Denmark have ... the acne causing P.acnes bacteria. Researchers believe found that when ... oxygen deprived location to seek shelter and grow. When an ... ability to live in the open joint areas, causing inflammation ... The best acne treatment ” explains why starting a normal ...
(Date:5/20/2013)... The World Molecular Imaging Society (WMIS) ... Baird as Executive Director. Baird will assume leadership ... The WMIS vision is to encompass and promote preclinical ... treat diseases in the developed and developing world. ... 2011 by integrating the Academy of Molecular Imaging and ...
Breaking Biology Technology:Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2WMIS Appoints Lisa Baird as Next Executive Director 2
... step , Karen Dolter Jeff Braman ,Stratagene ... efficiently,isolates high-quality total RNA from 10 5 ... 40 mg of tissue and includes an on-column DNA-removal ... the,easy-to-follow technique. The RNA isolation is performed within microspin ...
... ,Determine retroviral transduction efficiency and gene expression in,virtually any target ... Peter Vaillancourt ,Stratagene , We describe three new ViraPort retroviral ... , ... be used to determine transduction efficiency and gene expression in,virtually ...
... liposome-based transfection reagents , , D.J. Lowrie ... ,University of Cincinnati College of Medicine, Cincinnati, OH ... is enhanced by the use of,liposome-based reagents. Here ... into human adrenalcarcinoma cells using both LipoTAXI ...
Cached Biology Technology:Simple Isolation of RNA from Tissue and Cultured Cells 2Simple Isolation of RNA from Tissue and Cultured Cells 3Simple Isolation of RNA from Tissue and Cultured Cells 4Simple Isolation of RNA from Tissue and Cultured Cells 5Simple Isolation of RNA from Tissue and Cultured Cells 6Simple Isolation of RNA from Tissue and Cultured Cells 7Simple Isolation of RNA from Tissue and Cultured Cells 8Versatile Reporter Vectors for Monitoring Viral Transduction 2Versatile Reporter Vectors for Monitoring Viral Transduction 3Versatile Reporter Vectors for Monitoring Viral Transduction 4Versatile Reporter Vectors for Monitoring Viral Transduction 5Versatile Reporter Vectors for Monitoring Viral Transduction 6Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells 2Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells 3Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells 4
(Date:5/20/2013)... - A novel vaccine study from South Dakota ... will be unveiled at the American Association of Pharmaceutical ... place Monday, May 20 - Wednesday, May 22 at ... "The main goal of a vaccine is to stimulate ... causes the disease", explained Dr. Hemachand Tummala, assistant professor ...
(Date:5/19/2013)... that white men and women of European descent inherit ... lesser toe deformities, including hammer or claw toe. Findings ... heritability of foot disorders in humansappear in Arthritis ... on behalf of the American College of Rheumatology (ACR). ... 60% of older adults have foot disorders which may ...
(Date:5/18/2013)... The AGA Research Foundation is honored to announce the ... Digestive Cancer, which will support Andrew D. Rhim, MD, ... of Pennsylvania, Philadelphia, as he furthers his research on ... cancer progression. , "The AGA Research Foundation is humbled ... clinicians and AGA Legacy Society members," said Nicholas F. ...
Breaking Biology News(10 mins):Germ-fighting vaccine system makes great strides in delivery 2Blame your parents for bunion woes 2AGA Research Foundation grant furthers digestive cancer research 2
... social evolution to climate change, Cornell University entomologists show that ... simultaneously during a period of global warming. , This ... -- only 20 million to 22 million years ago, compared ... than 65 million years ago. , "We believe that climatic ...
... discovered a new bacterium in an immune-compromised patient, according ... The bacterium belongs to the family Acetobacteraceae and includes ... used in industry, such as vinegar-making. "This is ... by any of the Acetobacteraceae," according to the article. ...
... recently derived human gene trees by Alan R. Templeton, ... distinct major waves of human migration out of Africa ... ?the 'Out of Africa' replacement theory. , That theory ... years ago and wiped out existing populations of humans. ...
Cached Biology News:Sociality of sweat bees evolved simultaneously during climate change 2Scientists discover a new disease-causing bacterium in an immune-compromised patient 2New analysis shows three human migrations out of Africa 2
Marmoset plasma and serum - various quantities available...
3'-O-Methylguanosine 5'-Triphosphate, Sodium, 1 umol. Category: Nucleotides & Enzymes & Biochemicals, Nucleotides, Additional Nucleotide Products....
Natural Mouse Laminin is purified from the Engelbreth-Holm-Swarm (EHS) sarcoma and is provided in Tris-buffered saline....
EPH electrode, cathode, 1. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
Biology Products: